Hepatitis E Screening

Update January 2016 Introduction of Hepatitis E Virus (HEV) screened negative components

NHSBT plans to introduce hepatitis E virus (HEV) screened components following a recommendation from the Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO). Introduction of these components is now scheduled for 14 March 2016. 

 
Background

Following a significant increase in the number of reported cases of Hepatitis E virus (HEV) arising from infection acquired in the UK, SaBTO announced in August 2015 that they are assessing the implications of transmission of HEV by blood components, organs and tissues.
 
SaBTO wrote to clinicians in the field of transplantation to make them aware of the possibility that HEV may be transmitted through the use of blood components, through transplantation and through diet. This was followed with a recommendation that HEV negative components were required for specific patient groups:
  • Allogeneic stem cell/bone marrow transplantation
  • Solid organ transplantation 
NHSBT is planning to supply HEV negative components for these selected patient groups from early 2016. Below is further information that was distributed to Hospitals: